Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
recombinant human superoxide dismutase
- Development stage
- Unknown
- Lead developer
- Peking University Cancer Hospital & Institute
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Rectal, Vaginal
01
Overview
Recombinant human superoxide dismutase (rhSOD) is a biotechnologically produced version of the endogenous antioxidant enzyme that catalyzes the dismutation of superoxide radicals into oxygen and hydrogen peroxide. By neutralizing reactive oxygen species (ROS) generated during ionizing radiation, rhSOD protects healthy tissues from oxidative stress and subsequent inflammatory damage. It is currently being investigated in Phase 3 clinical trials, primarily led by Peking University Cancer Hospital, for the prevention and treatment of radiation-induced mucosal injuries. These include acute rectal injury (proctitis) and vaginal mucosal injury in patients undergoing concurrent chemoradiotherapy for cervical cancer. The drug is typically administered locally via enema or vaginal douching to provide site-specific protection.
- Other names
- rh-SODrecombinant human Cu,Zn-superoxide dismutasesudismase
Beyond the preview
Go deeper on recombinant human superoxide dismutase.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on recombinant human superoxide dismutase.